Indication
rnrn
Verigat is indicated for
rnrn· rnChronic Heart Failure
rnrn· rnHeart Failure with reduced ejectionrnfraction (<45%)
rnrn· rnWorsening Heart Failure event
rnrnDosage and Administration
rnrn
The recommended starting dose ofrnVerigat is 2.5 mg orally once daily with food. Double the dose of Verigatrnapproximately every 2 weeks to reach the target maintenance dose of 10 mg oncerndaily, as tolerated by the patient. For patients who are unable to swallowrnwhole tablet, Verigat may be crushed and mixed with water immediately beforernadministration. ORrnAS DIRECTED BY THE PHYSICIAN.
rnrnrnrn
Composition
normal\\\">mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\">Verigat 2.5 Tablet:
mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\">Each
film-coated tablet contains Vericiguat INN 2.5 mg.
normal\\\">mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\">Verigat 5 Tablet:
mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\">Each
film-coated tablet contains Vericiguat INN 5 mg.
normal\\\">mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\">Verigat 10 Tablet:
mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\">Each
film-coated tablet contains Vericiguat INN 10 mg.